Fig. 2From: Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in ChinaA, B Progression-free survival (PFS) and overall survival (OS) of all patients. C, D Comparison of progression-free survival (PFS) and overall survival (OS) between patients with stage I/II and III/IV diseaseBack to article page